अगला

स्वत: प्ले

FDA Approvals in NSCLC and Soft Tissue Sarcoma, Priority Review in Bladder Cancer, and More

2 विचारों • 07/18/23
शेयर करना
एम्बेड
administrator
administrator
ग्राहकों
0

Justin Gallagher reports two FDA approvals for immunotherapy in lung cancer, an approval in soft tissue sarcoma, a priority review designation in bladder cancer, an updated indication for a drug in prostate cancer, encouraging phase III results in bladder cancer, noninferiority findings in multiple myeloma, and a European approval in pancreatic cancer.

और दिखाओ
0 टिप्पणियाँ sort इसके अनुसार क्रमबद्ध करें
फेसबुक टिप्पणियाँ

अगला

स्वत: प्ले